"Middlesex Hospital at Middlesex Health: world-class medical technology, Magnet nurses, and some of Connecticut’s highest quality and patient satisfaction ratings."

During the past decade, Middlesex Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 37 clinical trials were completed, i.e. on average, 90.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 21 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Middlesex Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Exact Sciences Corporation" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Middlesex Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Middlesex Hospital" are "Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials), "Stage IIIB Breast Cancer AJCC v7" (6 trials), "Stage IIIC Breast Cancer AJCC v7" (6 trials) and "Breast Adenocarcinoma" (5 trials). Many other conditions were trialed in "Middlesex Hospital" in a lesser frequency.

Most popular intervention types in "Middlesex Hospital" are "Drug" (60 trials), "Other" (57 trials), "Biological" (23 trials), "Procedure" (11 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (19 trials), "Paclitaxel" (13 trials), "Carboplatin" (8 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Middlesex Hospital" are 58 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Middlesex Hospital". undefined are not yet recruiting, 9 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Middlesex Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Middlesex Hospital, 0 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Middlesex Hospital has several departments that took part in Clinical trials: "Middlesex Hospital Cancer Center" - 17 trials